LifeMD, Inc. LFMDP
20.62 USD -0.29 (-1.39%)
At closeNov 10, 2026, 4:15 PM EST
21.34 +0.72 +3.49%
After hours · Nov 10, 4:15 PM ET
20.90 Day range 22.70
18.50 52-week range 24.20
- YTD
- -6.44%
- 1 year
- -13.47%
News
globenewswire.com LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026 NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that the Company has rescheduled its third…
globenewswire.com LifeMD expands access to Lilly's self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide Eligible patients prescribed Zepbound® or Foundayo® through LifeMD can now receive authentic Lilly medicines at Lilly's self-pay prices through LifeMD's affiliated pharmacy Eligible patients…
globenewswire.com LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized…
globenewswire.com UPDATE - LifeMD Reports Second Quarter 2026 Results UPDATE this press release has been updated to remove a duplicate table. Second quarter 2026 revenue of $47.3 million, within the Company's guidance range of $47 million to $50 million; adjusted…
globenewswire.com LifeMD to Report Second Quarter 2026 Financial Results on August 5 NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six…
globenewswire.com LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to…
globenewswire.com LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program,…
globenewswire.com LifeMD Appoints Umesh Sripad as Chief Technology Officer Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two…
globenewswire.com LifeMD to Participate in Upcoming Investor Conferences NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming…
seekingalpha.com LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
globenewswire.com LifeMD to Report First Quarter 2026 Financial Results on May 6 NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months…
globenewswire.com LifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1 therapies through LillyDirect® LifeMD expands its weight…
globenewswire.com LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD's collaboration with Novo Nordisk Delivering up to $1,200 in annual patient savings on branded GLP-1…
globenewswire.com LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash…
seekingalpha.com LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript LifeMD, Inc. (LFMD) Q4 2025 Earnings Call Transcript
globenewswire.com LifeMD Reports Fourth Quarter and Full Year 2025 Results Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million. Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.
globenewswire.com LifeMD to Participate in Two Investor Conferences During March NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following…
globenewswire.com LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12…
globenewswire.com LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured…
globenewswire.com LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill Adds first and only FDA‑approved oral GLP‑1 to its virtual weight management offering, expanding access to affordable, branded treatment options Adds first and only FDA‑approved oral GLP‑1 to its…
benzinga.com LifeMD Q2 EPS $(0.06) Misses $(0.01) Estimate, Sales $62.200M Miss $66.343M Estimate LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.01) by 900 percent. This is a 200 percent decrease over earnings of $0.06 per…